Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06263426 · ClinicalTrials.gov registry record · NA
Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
A NA study of HIV, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 13
- Study locations
NCT06263426: Recruiting NA study of HIV, sponsored by Johns Hopkins University.
NCT06263426 is a NA study of HIV that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 200 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (54% lower). The trial reports 13 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06263426, a NA study of HIV, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 13
- Study locations
Study Summary
This research is being done to better understand rejection in transplant recipients with HIV who receive kidneys from donors with vs without HIV.
Primary Outcome
Proportion of participants who die or have graft rejection
Conditions Studied
Interventions
- OTHER HIV D+/R+
- OTHER HIV D-/R+
Study Locations (13)
New York
- New York University - New York
- Icahn School of Medicine at Mt. Sinai - New York
- Columbia University - New York
- Weill Cornell Medical Center - New York
California
- University of California, Los Angeles - Los Angeles
- University of California, San Diego - San Diego
- University of California, San Francisco - San Francisco
Alabama
- University of Alabama at Birmingham - Birmingham
Illinois
- Rush University Medical Center - Chicago
Louisiana
- Ochsner Clinic Foundation - New Orleans
Maryland
- Johns Hopkins University - Baltimore
Massachusetts
- Massachusetts General Hospital - Boston
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-05-22 |
| Est. Completion | 2029-09 |
| Phase | NA |
What NCT06263426 shows while recruiting
NCT06263426 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (54% lower).
The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 2 interventions - of which HIV D+/R+ is the first listed.
NCT06263426 lists 13 locations in 8 states (New York, California, Alabama).
Frequently Asked Questions
What is clinical trial NCT06263426 about?
NCT06263426 is a clinical study titled "Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)". This research is being done to better understand rejection in transplant recipients with HIV who receive kidneys from donors with vs without HIV.
What is the current status of trial NCT06263426?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-05-22. Estimated completion is 2029-09.
What conditions does trial NCT06263426 study?
This clinical trial studies the following conditions: HIV.
What interventions are being tested in trial NCT06263426?
The interventions under investigation include: HIV D+/R+ (OTHER), HIV D-/R+ (OTHER).
Who is sponsoring clinical trial NCT06263426?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06263426 being conducted?
This trial has 13 study locations across Alabama, California, Illinois, Louisiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06263426's enrollment target sits among peer trials
200 103rd of 303 higher than 188 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI